{"transactions":[{"id":962109,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":71102,"kind":"person","name":"Margolin Richard A","position":1,"cik":"0001822761","reported_name":"Margolin Richard A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-12-19T16:18:05.000Z","date":"2025-12-18","kind":"grant","planned":false,"acquired":true,"shares":8200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award (the \"Option\") was made in accordance with the terms of the 2020 Equity Incentive Plan (the \"2020 Plan\") of Reviva Pharmaceuticals Holdings, Inc. (the \"Company\"). The Option will vest at the rate of one hundred percent (100%) of the shares of common stock, par value $0.0001 per share (\"Common Stock\"), subject thereto upon the one year anniversary of the date of grant, provided that the reporting person remains a director of the Company through such vesting date. The exercise price is based on the closing price of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan."}],"balance_after":8200,"derivative":{"exercise_price":0.5848,"expiration_date":"2035-12-17","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":8200},"source":{"system":"sec-edgar","filing":"0001437749-25-038445","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822761/000143774925038445/rdgdoc.xml","form_type":"4"}},{"id":1334075,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":71102,"kind":"person","name":"Margolin Richard A","position":1,"cik":"0001822761","reported_name":"Margolin Richard A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-12-12T16:34:45.000Z","date":"2024-12-10","kind":"grant","planned":false,"acquired":true,"shares":8200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award (the \"Option\") was made in accordance with the terms of the 2020 Equity Incentive Plan (the \"2020 Plan\") of Reviva Pharmaceuticals Holdings, Inc. (the \"Company\"). The Option will vest at the rate of one hundred percent (100%) of the shares of common stock (\"Common Stock\") subject thereto upon the one year anniversary of the date of grant, provided that the reporting person remains a director of the Company through such vesting date. The exercise price is based on the closing price of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan."}],"balance_after":8200,"derivative":{"exercise_price":2.52,"expiration_date":"2034-12-09","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":8200},"source":{"system":"sec-edgar","filing":"0001437749-24-037369","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822761/000143774924037369/rdgdoc.xml","form_type":"4"}},{"id":1742417,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":71102,"kind":"person","name":"Margolin Richard A","position":1,"cik":"0001822761","reported_name":"Margolin Richard A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-11-14T16:20:15.000Z","date":"2023-11-13","kind":"grant","planned":false,"acquired":true,"shares":8200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the \"2020 Plan\"). The Option will vest at the rate of one hundred percent (100%) of the shares subject thereto upon the one year anniversary of the date of grant, provided that Awardee remains a director of the Company through such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan."}],"balance_after":8200,"derivative":{"exercise_price":6.04,"expiration_date":"2033-11-12","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":8200},"source":{"system":"sec-edgar","filing":"0001437749-23-031989","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822761/000143774923031989/rdgdoc.xml","form_type":"4"}},{"id":2118173,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":71102,"kind":"person","name":"Margolin Richard A","position":1,"cik":"0001822761","reported_name":"Margolin Richard A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-11-14T09:00:48.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the \"2020 Plan\"). The Option will vest at the rate of one hundred percent (100%) of the shares subject thereto upon the one year anniversary of the date of grant, provided that Awardee remains a director of the Company through such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan."}],"balance_after":3900,"derivative":{"exercise_price":5.13,"expiration_date":"2032-11-09","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0001437749-22-027081","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822761/000143774922027081/rdgdoc.xml","form_type":"4"}},{"id":2477452,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":71102,"kind":"person","name":"Margolin Richard A","position":1,"cik":"0001822761","reported_name":"Margolin Richard A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-12-10T16:31:16.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the \"2020 Plan\"). The Option will vest at the rate of one hundred percent (100%) of the shares subject thereto upon the one year anniversary of the date of grant, provided that Awardee remains a director of the Company through such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan."}],"balance_after":5300,"derivative":{"exercise_price":3.78,"expiration_date":"2031-12-07","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001437749-21-028320","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822761/000143774921028320/rdgdoc.xml","form_type":"4"}},{"id":2666601,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":71102,"kind":"person","name":"Margolin Richard A","position":1,"cik":"0001822761","reported_name":"Margolin Richard A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T16:30:56.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the \"2020 Plan\"). The Option will vest at the rate of thirty-three percent (33%) of the shares subject thereto upon the one year anniversary of December 14, 2020, and as to an additional thirty-three percent (33%) of the shares subject to the Option on each successive one year anniversary thereafter, provided that Awardee remains a director of the Company through each such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan."}],"balance_after":4000,"derivative":{"exercise_price":4.73,"expiration_date":"2031-06-14","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001437749-21-014949","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822761/000143774921014949/rdgdoc.xml","form_type":"4"}}]}